211 related articles for article (PubMed ID: 33792220)
1. Deregulation of JAK2 signaling underlies primary cutaneous CD8
Bastidas Torres AN; Cats D; Out-Luiting JJ; Fanoni D; Mei H; Venegoni L; Willemze R; Vermeer MH; Berti E; Tensen CP
Haematologica; 2022 Mar; 107(3):702-714. PubMed ID: 33792220
[TBL] [Abstract][Full Text] [Related]
2. Array-based CGH of primary cutaneous CD8+ aggressive EPIDERMO-tropic cytotoxic T-cell lymphoma.
Fanoni D; Corti L; Alberti-Violetti S; Tensen CP; Venegoni L; Vermeer M; Willemze R; Berti E
Genes Chromosomes Cancer; 2018 Dec; 57(12):622-629. PubMed ID: 30307677
[TBL] [Abstract][Full Text] [Related]
3. Vulvar Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma.
Morse DC; Park KE; Chitsazzadeh V; Li S; Young K; Gunther JR; Dabaja BS; Duvic M
Int J Gynecol Pathol; 2021 May; 40(3):229-233. PubMed ID: 33741766
[TBL] [Abstract][Full Text] [Related]
4. [Facial ulcerated nodules revealing primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma].
Rolland M; Dinulescu M; Saillard C; Battistella M; Le Gall F; Lhomme F; Gangneux JP; Dupuy A; Adamski H
Ann Dermatol Venereol; 2020 Nov; 147(11):764-768. PubMed ID: 32527516
[TBL] [Abstract][Full Text] [Related]
5. t(8;9)(p22;p24)/PCM1-JAK2 activates SOCS2 and SOCS3 via STAT5.
Ehrentraut S; Nagel S; Scherr ME; Schneider B; Quentmeier H; Geffers R; Kaufmann M; Meyer C; Prochorec-Sobieszek M; Ketterling RP; Knudson RA; Feldman AL; Kadin ME; Drexler HG; MacLeod RA
PLoS One; 2013; 8(1):e53767. PubMed ID: 23372669
[TBL] [Abstract][Full Text] [Related]
6. Primary cutaneous aggressive epidermotropic CD8(+) cytotoxic T-cell lymphoma with atypical presentation.
Kim SK; Kim YC; Kang HY
J Dermatol; 2006 Sep; 33(9):632-4. PubMed ID: 16958809
[TBL] [Abstract][Full Text] [Related]
7. [Aggressive T cytotoxic CD8+ epidermotropic cutaneous lymphoma: a case in a patient with Steinert's myotonic dystrophy].
Du-Thanh A; Durand L; Costes V; Guillot B; Dereure O
Ann Dermatol Venereol; 2006 Dec; 133(12):991-4. PubMed ID: 17185931
[TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous aggressive epidermotropic CD8+ T cell lymphoma with a chronic and indolent course. Is this different from peripheral T cell lymphoma?
Gomez Vazquez M; Navarra Amayuelas R
Dermatol Online J; 2012 Mar; 18(3):11. PubMed ID: 22483522
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous CD8+ cytotoxic T-cell lymphoma involving the epidermis and subcutis in a young child.
Wang L; Gao T; Wang G
J Cutan Pathol; 2015 Apr; 42(4):271-5. PubMed ID: 25458991
[TBL] [Abstract][Full Text] [Related]
10. CD4/CD8 double-negative T-cell lymphoma: a variant of primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma?
Miyauchi T; Abe R; Morita Y; Adachi M; Shiba K; Hamade Y; Saito N; Nishimura M; Ibata M; Okada K; Shigematsu A; Endo T; Kawai K; Teshima T; Shimizu H
Acta Derm Venereol; 2015 Nov; 95(8):1024-5. PubMed ID: 25792011
[No Abstract] [Full Text] [Related]
11. [Primary cutaneous aggressive epidermotropic cytotoxic CD8 positive T cell lymphoma: report of one case].
Intriago B M; Peña O C; Gray H AM; Cabrera C ME; Martínez C V
Rev Med Chil; 2012 Mar; 140(3):368-72. PubMed ID: 22689119
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma.
Gormley RH; Hess SD; Anand D; Junkins-Hopkins J; Rook AH; Kim EJ
J Am Acad Dermatol; 2010 Feb; 62(2):300-7. PubMed ID: 19944484
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: proposed diagnostic criteria and therapeutic evaluation.
Nofal A; Abdel-Mawla MY; Assaf M; Salah E
J Am Acad Dermatol; 2012 Oct; 67(4):748-59. PubMed ID: 22226429
[TBL] [Abstract][Full Text] [Related]
14. [Cutaneous CD8+ epidermotropic cytotoxic T-cell lymphoma with aggressive course].
Poszepczynska-Guigné E; Jagou M; Wechsler J; Dieng MT; Revuz J; Bagot M
Ann Dermatol Venereol; 2006 Mar; 133(3):253-6. PubMed ID: 16800177
[TBL] [Abstract][Full Text] [Related]
15. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
[TBL] [Abstract][Full Text] [Related]
16. A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases.
Saggini A; Gulia A; Argenyi Z; Fink-Puches R; Lissia A; Magaña M; Requena L; Simonitsch I; Cerroni L
Am J Surg Pathol; 2010 Aug; 34(8):1168-75. PubMed ID: 20661014
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma with a CD15(+)CD30(-) phenotype.
Yoshizawa N; Yagi H; Horibe T; Takigawa M; Sugiura M
Eur J Dermatol; 2007; 17(5):441-2. PubMed ID: 17673391
[TBL] [Abstract][Full Text] [Related]
18. Central nervous system relapse of primary cutaneous CD8
Oun H; Wilson M; Leach M; McKay P
Br J Haematol; 2021 Apr; 193(1):9. PubMed ID: 33336793
[No Abstract] [Full Text] [Related]
19. Successful Cord Blood Stem Cell Transplantation for Primary Cutaneous CD8-positive Aggressive Epidermotropic Cytotoxic T-cell Lymphoma Complicated with Cerebral Infiltration.
Ichikawa S; Fukuhara N; Hatta S; Himuro M; Katsushima H; Nasu K; Ono K; Inokura K; Kobayashi M; Onishi Y; Fujii H; Ishizawa K; Ichinohasama R; Harigae H
Intern Med; 2018 Jul; 57(14):2051-2055. PubMed ID: 29526962
[TBL] [Abstract][Full Text] [Related]
20. Erythema multiforme-like lesions in primary cutaneous aggressive cytotoxic epidermotropic CD8+ T-cell lymphoma: A diagnostic and therapeutic challenge.
Tomasini C; Novelli M; Fanoni D; Berti EF
J Cutan Pathol; 2017 Oct; 44(10):867-873. PubMed ID: 28644551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
